Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
TIDES Europe 2024TIDES Europe 2024
Not Confirmed
Not Confirmed
12-14 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
TIDES Europe 2024TIDES Europe 2024
Industry Trade Show
Not Confirmed
12-14 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
02 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amo-pharma-completes-meeting-with-us-fda-and-outlines-plans-to-advance-clinical-development-of-amo-02-tideglusib-in-treatment-of-myotonic-dystrophy-302133891.html
15 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amo-pharma-announces-collaboration-with-population-health-research-institute-to-advance-proof-of-concept-clinical-trial-to-assess-efficacy-of-tideglusib-in-treatment-of-arrhythmogenic-cardiomyopathy-302062622.html
19 Sep 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amo-pharma-announces-preclinical-data-showing-amo-02-improves-muscle-function-glucose-handling-and-cns-function-in-mouse-models-of-duchenne-muscular-dystrophy-301931362.html
06 Sep 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amo-pharma-announces-affirming-data-from-reach-cdm-clinical-trial-for-amo-02-in-treatment-of-myotonic-dystrophy-301918241.html
25 Apr 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amo-pharma-announces-completion-of-treatment-of-last-patient-in-pivotal-reach-cdm-clinical-trial-in-myotonic-dystrophy-301806216.html
27 Feb 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amo-pharma-announces-mhra-confirmation-of-cdm1-rs-as-approvable-primary-outcome-measure-in-myotonic-dystrophy-301755604.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?